Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
Modulating immune inhibitory pathways has been a major recent breakthrough in cancer treatment. Checkpoint blockade antibodies targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programed cell-death prote...